Does AMPICILLIN Cause Bladder transitional cell carcinoma? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Bladder transitional cell carcinoma have been filed in association with AMPICILLIN (Ampicillin and Sulbactam). This represents 0.6% of all adverse event reports for AMPICILLIN.
23
Reports of Bladder transitional cell carcinoma with AMPICILLIN
0.6%
of all AMPICILLIN reports
0
Deaths
23
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From AMPICILLIN?
Of the 23 reports, 23 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPICILLIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does AMPICILLIN Cause?
Drug hypersensitivity (566)
Drug ineffective (540)
Maternal exposure during pregnancy (485)
Foetal exposure during pregnancy (474)
Premature baby (404)
Premature delivery (330)
Product use in unapproved indication (224)
Off label use (204)
Rash (150)
Low birth weight baby (127)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which AMPICILLIN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
AMPICILLIN vs AMPICILLIN\SULBACTAM
AMPICILLIN vs AMPRENAVIR
AMPICILLIN vs AMPYRA
AMPICILLIN vs AMRUBICIN
AMPICILLIN vs AMSACRINE